Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Opioid Consumption After Knee Arthroscopy.

Wojahn RD, Bogunovic L, Brophy RH, Wright RW, Matava MJ, Green JR 4th, Zalomek CA, Haas AK, Holloway WL, Garofoli EA, Smith MV.

J Bone Joint Surg Am. 2018 Oct 3;100(19):1629-1636. doi: 10.2106/JBJS.18.00049.

PMID:
30277992
2.

Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group.

MARS Group, Cooper DE, Dunn WR, Huston LJ, Haas AK, Spindler KP, Allen CR, Anderson AF, DeBerardino TM, Lantz BBA, Mann B, Stuart MJ, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler V JB, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ, Wright RW.

Am J Sports Med. 2018 Oct;46(12):2836-2841. doi: 10.1177/0363546518777732. Epub 2018 Jun 8.

PMID:
29882693
3.

Risk Factors and Predictors of Significant Chondral Surface Change From Primary to Revision Anterior Cruciate Ligament Reconstruction: A MOON and MARS Cohort Study.

MARS Group, Magnussen RA, Borchers JR, Pedroza AD, Huston LJ, Haas AK, Spindler KP, Wright RW, Kaeding CC, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Lantz BA, Mann B, Stuart MJ, Albright JP, Amendola A, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB 5th, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2018 Mar;46(3):557-564. doi: 10.1177/0363546517741484. Epub 2017 Dec 15.

PMID:
29244532
4.

Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.

Killian T, Dickopf S, Haas AK, Kirstenpfad C, Mayer K, Brinkmann U.

Sci Rep. 2017 Nov 13;7(1):15480. doi: 10.1038/s41598-017-15206-x.

5.

Surgical Predictors of Clinical Outcomes After Revision Anterior Cruciate Ligament Reconstruction.

MARS Group, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Haas AK, Huston LJ, Lantz BBA, Mann B, Nwosu SK, Spindler KP, Stuart MJ, Wright RW, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB 5th, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2017 Sep;45(11):2586-2594. doi: 10.1177/0363546517712952. Epub 2017 Jul 11.

6.

Subsequent Surgery After Revision Anterior Cruciate Ligament Reconstruction: Rates and Risk Factors From a Multicenter Cohort.

MARS Group, Ding DY, Zhang AL, Allen CR, Anderson AF, Cooper DE, DeBerardino TM, Dunn WR, Haas AK, Huston LJ, Lantz BBA, Mann B, Spindler KP, Stuart MJ, Wright RW, Albright JP, Amendola AN, Andrish JT, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Bechler JR, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB 5th, Campbell JD, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, Dahm DL, David TS, Flanigan DC, Frederick RW, Ganley TJ, Garofoli EA, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Hosea TM, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ.

Am J Sports Med. 2017 Jul;45(9):2068-2076. doi: 10.1177/0363546517707207. Epub 2017 May 30.

7.

Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor.

Stahl S, da Silva Mateus Seidl AR, Ducret A, Kux van Geijtenbeek S, Michel S, Racek T, Birzele F, Haas AK, Rueger R, Gerg M, Niederfellner G, Pastan I, Brinkmann U.

Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10732-7. doi: 10.1073/pnas.1512863112. Epub 2015 Aug 10.

8.

Anterior Cruciate Ligament Reconstruction Rehabilitation: MOON Guidelines.

Wright RW, Haas AK, Anderson J, Calabrese G, Cavanaugh J, Hewett TE, Lorring D, McKenzie C, Preston E, Williams G; MOON Group.

Sports Health. 2015 May;7(3):239-43. doi: 10.1177/1941738113517855.

9.

Association of Meniscal Status, Lower Extremity Alignment, and Body Mass Index With Chondrosis at Revision Anterior Cruciate Ligament Reconstruction.

Brophy RH, Haas AK, Huston LJ, Nwosu SK; MARS Group, Wright RW.

Am J Sports Med. 2015 Jul;43(7):1616-22. doi: 10.1177/0363546515578838. Epub 2015 Apr 21.

10.

Outcome of All-Inside Second-Generation Meniscal Repair: Minimum Five-Year Follow-up.

Bogunovic L, Kruse LM, Haas AK, Huston LJ, Wright RW.

J Bone Joint Surg Am. 2014 Aug 6;96(15):1303-1307.

11.

Differences in mechanisms of failure, intraoperative findings, and surgical characteristics between single- and multiple-revision ACL reconstructions: a MARS cohort study.

Chen JL, Allen CR, Stephens TE, Haas AK, Huston LJ, Wright RW, Feeley BT; Multicenter ACL Revision Study (MARS) Group.

Am J Sports Med. 2013 Jul;41(7):1571-8. doi: 10.1177/0363546513487980. Epub 2013 May 22.

12.

Surgery versus physical therapy for a meniscal tear and osteoarthritis.

Katz JN, Brophy RH, Chaisson CE, de Chaves L, Cole BJ, Dahm DL, Donnell-Fink LA, Guermazi A, Haas AK, Jones MH, Levy BA, Mandl LA, Martin SD, Marx RG, Miniaci A, Matava MJ, Palmisano J, Reinke EK, Richardson BE, Rome BN, Safran-Norton CE, Skoniecki DJ, Solomon DH, Smith MV, Spindler KP, Stuart MJ, Wright J, Wright RW, Losina E.

N Engl J Med. 2013 May 2;368(18):1675-84. doi: 10.1056/NEJMoa1301408. Epub 2013 Mar 18. Erratum in: N Engl J Med. 2013 Aug 15;369(7):683.

13.

Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists.

Hoyer I, Haas AK, Kreuchwig A, Schülein R, Krause G.

Biochem Soc Trans. 2013 Feb 1;41(1):213-7. doi: 10.1042/BST20120319. Review.

14.

Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.

Metz S, Panke C, Haas AK, Schanzer J, Lau W, Croasdale R, Hoffmann E, Schneider B, Auer J, Gassner C, Bossenmaier B, Umana P, Sustmann C, Brinkmann U.

Protein Eng Des Sel. 2012 Oct;25(10):571-80. Epub 2012 Sep 13.

15.

Generation of fluorescent IgG fusion proteins in mammalian cells.

Haas AK, Mayer K, Brinkmann U.

Methods Mol Biol. 2012;901:265-76. doi: 10.1007/978-1-61779-931-0_17.

PMID:
22723107
16.

Bispecific antibody derivatives based on full-length IgG formats.

Grote M, Haas AK, Klein C, Schaefer W, Brinkmann U.

Methods Mol Biol. 2012;901:247-63. doi: 10.1007/978-1-61779-931-0_16.

PMID:
22723106
17.

Association between previous meniscal surgery and the incidence of chondral lesions at revision anterior cruciate ligament reconstruction.

Brophy RH, Wright RW, David TS, McCormack RG, Sekiya JK, Svoboda SJ, Huston LJ, Haas AK, Steger-May K; Multicenter ACL Revision Study (MARS) Group.

Am J Sports Med. 2012 Apr;40(4):808-14. doi: 10.1177/0363546512437722. Epub 2012 Feb 28.

18.

Human-protein-derived peptides for intracellular delivery of biomolecules.

Haas AK, Maisel D, Adelmann J, von Schwerin C, Kahnt I, Brinkmann U.

Biochem J. 2012 Mar 15;442(3):583-93. doi: 10.1042/BJ20111973.

PMID:
22150630
19.

From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs).

Kleinau G, Hoyer I, Kreuchwig A, Haas AK, Rutz C, Furkert J, Worth CL, Krause G, Schülein R.

J Biol Chem. 2011 Jul 22;286(29):25859-71. doi: 10.1074/jbc.M110.196980. Epub 2011 May 17.

20.

Bispecific digoxigenin-binding antibodies for targeted payload delivery.

Metz S, Haas AK, Daub K, Croasdale R, Stracke J, Lau W, Georges G, Josel HP, Dziadek S, Hopfner KP, Lammens A, Scheuer W, Hoffmann E, Mundigl O, Brinkmann U.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8194-9. doi: 10.1073/pnas.1018565108. Epub 2011 May 2.

21.

Descriptive epidemiology of the Multicenter ACL Revision Study (MARS) cohort.

MARS Group, Wright RW, Huston LJ, Spindler KP, Dunn WR, Haas AK, Allen CR, Cooper DE, DeBerardino TM, Lantz BB, Mann BJ, Stuart MJ.

Am J Sports Med. 2010 Oct;38(10):1979-86. doi: 10.1177/0363546510378645.

22.

Fluorescent Citrine-IgG fusion proteins produced in mammalian cells.

Haas AK, von Schwerin C, Matscheko D, Brinkmann U.

MAbs. 2010 Nov-Dec;2(6):648-61. doi: 10.4161/mabs.2.6.13179. Epub 2010 Nov 1.

23.

Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.

Haas AK, Kleinau G, Hoyer I, Neumann S, Furkert J, Rutz C, Schülein R, Gershengorn MC, Krause G.

Cell Mol Life Sci. 2011 Jan;68(1):159-67. doi: 10.1007/s00018-010-0451-2. Epub 2010 Jul 22.

24.

Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor.

Kleinau G, Haas AK, Neumann S, Worth CL, Hoyer I, Furkert J, Rutz C, Gershengorn MC, Schülein R, Krause G.

FASEB J. 2010 Jul;24(7):2347-54. doi: 10.1096/fj.09-149146. Epub 2010 Feb 23.

25.

Multiple Rab GTPase binding sites in GCC185 suggest a model for vesicle tethering at the trans-Golgi.

Hayes GL, Brown FC, Haas AK, Nottingham RM, Barr FA, Pfeffer SR.

Mol Biol Cell. 2009 Jan;20(1):209-17. doi: 10.1091/mbc.E08-07-0740. Epub 2008 Oct 22.

26.

Analysis of Rab GTPase and GTPase-activating protein function at primary cilia.

Yoshimura S, Haas AK, Barr FA.

Methods Enzymol. 2008;439:353-64. doi: 10.1016/S0076-6879(07)00426-0.

PMID:
18374177
27.

Analysis of GTPase-activating proteins: Rab1 and Rab43 are key Rabs required to maintain a functional Golgi complex in human cells.

Haas AK, Yoshimura S, Stephens DJ, Preisinger C, Fuchs E, Barr FA.

J Cell Sci. 2007 Sep 1;120(Pt 17):2997-3010. Epub 2007 Aug 7.

28.

Functional dissection of Rab GTPases involved in primary cilium formation.

Yoshimura S, Egerer J, Fuchs E, Haas AK, Barr FA.

J Cell Biol. 2007 Jul 30;178(3):363-9. Epub 2007 Jul 23.

29.

Specific Rab GTPase-activating proteins define the Shiga toxin and epidermal growth factor uptake pathways.

Fuchs E, Haas AK, Spooner RA, Yoshimura S, Lord JM, Barr FA.

J Cell Biol. 2007 Jun 18;177(6):1133-43. Epub 2007 Jun 11.

30.

COP sets TRAPP for vesicles.

Haas AK, Barr FA.

Dev Cell. 2007 Mar;12(3):326-7.

31.

A GTPase-activating protein controls Rab5 function in endocytic trafficking.

Haas AK, Fuchs E, Kopajtich R, Barr FA.

Nat Cell Biol. 2005 Sep;7(9):887-93. Epub 2005 Aug 7.

PMID:
16086013

Supplemental Content

Support Center